Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/23 16:05 | 9/14/23 | ALIM | Health | Drug | Pharmaceutical Preparations | Caligan Partners LP | NY | T | P.d | 1,963 | 3.39 | 0 | 579 | 2 | 33,091 | I | |||||||||||||||
5/19/23 17:17 | 5/17/23 | ALIM | Health | Drug | Pharmaceutical Preparations | Morgan Adam | GA | DT | P.d | 2,383 | 1.70 | 0 | 1,402 | 544 | 1,660 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |